An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Purushothaman JambulingamVijesh Shreedhar KuttiattKaliannagounder KrishnamoorthySwaminathan SubramanianAdinarayanan SrividyaHari Kishan K RajuManju RahiRoopali K SomaniMallanna K SuryaprakashGangeshwar P DwivediGary J WeilPublished in: PLoS neglected tropical diseases (2021)
Clinical Trial Registry of India (CTRI No/2016/10/007399).